Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis.

Grigoriadis S, VonderPorten EH, Mamisashvili L, Eady A, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE.

J Clin Psychiatry. 2013 Apr;74(4):e309-20. doi: 10.4088/JCP.12r07967. Review.

PMID:
23656856
2.

Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence.

Grigoriadis S, VonderPorten EH, Mamisashvili L, Roerecke M, Rehm J, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE.

J Clin Psychiatry. 2013 Apr;74(4):e293-308. doi: 10.4088/JCP.12r07966. Review.

3.

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.

Ross LE, Grigoriadis S, Mamisashvili L, Vonderporten EH, Roerecke M, Rehm J, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A.

JAMA Psychiatry. 2013 Apr;70(4):436-43. doi: 10.1001/jamapsychiatry.2013.684. Review.

PMID:
23446732
4.

Meta-analysis: antidepressant exposure during pregnancy is associated with poor neonatal adaptation.

Pedersen LH.

Evid Based Med. 2014 Apr;19(2):76. doi: 10.1136/eb-2013-101490. Epub 2013 Sep 19. No abstract available.

PMID:
24052398
5.

The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis.

Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Radford K, Martinovic J, Ross LE.

J Clin Psychiatry. 2013 Apr;74(4):e321-41. doi: 10.4088/JCP.12r07968. Review.

PMID:
23656857
6.

Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.

Maschi S, Clavenna A, Campi R, Schiavetti B, Bernat M, Bonati M.

BJOG. 2008 Jan;115(2):283-9. Epub 2007 Sep 27.

7.

Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature.

Suri R, Lin AS, Cohen LS, Altshuler LL.

J Clin Psychiatry. 2014 Oct;75(10):e1142-52. doi: 10.4088/JCP.13r08926. Review.

PMID:
25373125
8.

Risk for Autism Spectrum Disorders According to Period of Prenatal Antidepressant Exposure: A Systematic Review and Meta-analysis.

Mezzacappa A, Lasica PA, Gianfagna F, Cazas O, Hardy P, Falissard B, Sutter-Dallay AL, Gressier F.

JAMA Pediatr. 2017 Jun 1;171(6):555-563. doi: 10.1001/jamapediatrics.2017.0124. Review.

PMID:
28418571
9.

Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.

Bahadue FL, Soll R.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD001456. doi: 10.1002/14651858.CD001456.pub2. Review.

PMID:
23152207
10.

Paroxetine use during pregnancy: is it safe?

Thormahlen GM.

Ann Pharmacother. 2006 Oct;40(10):1834-7. Epub 2006 Aug 22. Review.

PMID:
16926304
11.

Neonate characteristics after maternal use of antidepressants in late pregnancy.

Källén B.

Arch Pediatr Adolesc Med. 2004 Apr;158(4):312-6.

PMID:
15066868
12.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181
13.

Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.

Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE.

BMJ. 2014 Jan 14;348:f6932. doi: 10.1136/bmj.f6932. Review.

14.

Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.

Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM.

Mol Psychiatry. 2008 Jan;13(1):65-73. Epub 2007 May 22.

PMID:
17519929
15.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
16.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
18.

Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.

Lewis AJ, Galbally M, Opie G, Buist A.

Aust N Z J Psychiatry. 2010 May;44(5):482-7. doi: 10.3109/00048670903559593.

PMID:
20397792
19.

Antidepressant use in pregnancy: an evaluation of adverse outcomes excluding malformation.

Lorenzo L, Einarson A.

Isr J Psychiatry Relat Sci. 2014;51(2):94-104. Review.

20.

Antidepressant use in pregnancy: a critical review focused on risks and controversies.

Byatt N, Deligiannidis KM, Freeman MP.

Acta Psychiatr Scand. 2013 Feb;127(2):94-114. doi: 10.1111/acps.12042. Epub 2012 Dec 14. Review.

Supplemental Content

Support Center